Pio Pharm Denmark ApS Financials, key figures and credit report
Gross profit -2 363.5 kDKK FY 2025 +74.9% vs 2024
EBIT -19 137.3 kDKK FY 2025 -23.3% vs 2024
Net debt 63 598.6 kDKK FY 2025 +41.7% vs 2024
Quick ratio 0.0 FY 2025 -0.1 vs 2024
Income statement (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | -7 406.88 | -9 411.35 | -2 363.49 |
| Employee benefit expenses | -1 234.05 | -5 069.64 | -10 932.07 |
| Other operating expenses | -1 294.06 | ||
| Total depreciation | -5.78 | -1 036.42 | -4 547.63 |
| EBIT | -8 646.71 | -15 517.41 | -19 137.26 |
| Other financial income | 1.03 | 8.94 | 12.29 |
| Other financial expenses | -19.71 | - 744.20 | -2 567.70 |
| Pre-tax profit | -8 665.39 | -16 252.67 | -21 692.67 |
| Net earnings | -8 665.39 | -16 252.67 | -21 692.67 |
Assets (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Intangible assets total | |||
| Buildings | 7 949.11 | 20 411.28 | |
| Machinery and equipment | 34.22 | 1 317.72 | 8 937.76 |
| Advance payments and construction in progress | 6 761.45 | 24 023.32 | |
| Tangible assets total | 6 795.67 | 33 290.15 | 29 349.03 |
| Investments total | |||
| Long term receivables total | |||
| Raw materials and consumables | 370.81 | 6 386.54 | 6 024.64 |
| Finished products/goods | 58.98 | 2 536.85 | |
| Advance payments | 300.58 | 255.12 | |
| Inventories total | 370.81 | 6 746.10 | 8 816.61 |
| Current trade debtors | 675.12 | 33.94 | |
| Current amounts owed by group member comp. | 14.38 | ||
| Prepayments and accrued income | 129.41 | 153.73 | 115.54 |
| Current other receivables | 3 223.79 | 1 823.21 | 946.85 |
| Short term receivables total | 3 353.20 | 2 652.06 | 1 110.70 |
| Cash and bank deposits | 313.18 | 3 670.52 | 1 989.15 |
| Cash and cash equivalents | 313.18 | 3 670.52 | 1 989.15 |
| Balance sheet total (assets) | 10 832.86 | 46 358.83 | 41 265.50 |
Equity and liabilities (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Share capital | 8 833.33 | 17 666.67 | 17 666.67 |
| Retained earnings | -8 665.39 | -24 918.06 | |
| Profit of the financial year | -8 665.39 | -16 252.67 | -21 692.67 |
| Shareholders equity total | 167.94 | -7 251.39 | -28 944.06 |
| Non-current liabilities total | |||
| Advances received | 2 508.30 | ||
| Current trade creditors | 916.55 | 4 471.61 | 1 273.38 |
| Current owed to group member | 9 389.12 | 48 565.70 | 65 587.74 |
| Other non-interest bearing current liabilities | 359.25 | 572.91 | 840.14 |
| Current liabilities total | 10 664.92 | 53 610.22 | 70 209.56 |
| Balance sheet total (liabilities) | 10 832.86 | 46 358.83 | 41 265.50 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated